MedPath

WELLSTAR HEALTH SYSTEM

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:0

Trial Phases

3 Phases

Phase 2:1
Phase 4:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
1 (33.3%)
Phase 2
1 (33.3%)
Phase 4
1 (33.3%)

Comparison of Solitaire to Embotrap to Treat Large Vessel Occlusion in Acute Ischemic Stroke (SOLTRAP Study)

Recruiting
Conditions
Acute Ischemic Stroke
First Posted Date
2022-08-26
Last Posted Date
2022-08-26
Lead Sponsor
WellStar Health System
Target Recruit Count
418
Registration Number
NCT05518240
Locations
πŸ‡ΊπŸ‡Έ

Wellstar Kennestone Hospital, Marietta, Georgia, United States

πŸ‡ΊπŸ‡Έ

Wellstar North Fulton Hospital, Roswell, Georgia, United States

Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease

Phase 4
Conditions
COVID-19
Interventions
First Posted Date
2020-06-12
Last Posted Date
2020-06-16
Lead Sponsor
WellStar Health System
Target Recruit Count
700
Registration Number
NCT04429867
Locations
πŸ‡ΊπŸ‡Έ

Wellstar Kennestone Hospital, Marietta, Georgia, United States

REperfusion With Cooling in CerebraL Acute IscheMia II

Phase 2
Withdrawn
Conditions
Hypothermia
Ischemic Stroke
First Posted Date
2015-04-08
Last Posted Date
2016-02-17
Lead Sponsor
WellStar Health System
Registration Number
NCT02411877
Locations
πŸ‡ΊπŸ‡Έ

WellStar Kennestone Regional Medical Center, Marietta, Georgia, United States

Reperfusion With Cooling in Cerebral Acute Ischemia II

Not Applicable
Withdrawn
Conditions
Ischemic Stroke
Hypothermia
First Posted Date
2012-11-20
Last Posted Date
2018-09-13
Lead Sponsor
WellStar Health System
Registration Number
NCT01728649
Locations
πŸ‡ΊπŸ‡Έ

Grady Memorial Hospital, Atlanta, Georgia, United States

News

AI Lung Cancer Risk Model Sybil Validated in Predominantly Black Patient Population

Researchers at the University of Illinois Hospital & Clinics validated the Sybil AI model's accuracy in predicting lung cancer risk within a predominantly Black patient population, addressing critical racial disparities in screening.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.